KETOROLAC TROMETHAMINE TABLETS

TEVA

Revision date : 2013-07-31

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

9004-64-2

Name of the chemical

hydroxypropylcellulose

Concentration

N/A

EC/CAS

9004-65-3

Name of the chemical

methylhydroxypropylcellulose

Concentration

N/A

EC/CAS

200-559-2/63-42-3

Name of the chemical

Lactose C12H22O11

Concentration

N/A

EC/CAS

232-674-9/9004-34-6

Name of the chemical

cellulose

Concentration

N/A

EC/CAS

200-338-0/57-55-6

Name of the chemical

1,2-propanediol

Concentration

N/A

EC/CAS

13463-67-7

Name of the chemical

Reaction mass of titanium dioxide and silver chloride

Concentration

236-675-

EC/CAS

209-150-3

Name of the chemical

Aluminium, zinc, magnesium and calcium stearates

Concentration

N/A

General Information

Revision date

2013-07-31

Product name

KETOROLAC TROMETHAMINE TABLETS

Chemical name

(±)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, compound

Manufacturer Name

TEVA

Emergency telephone

1-800/424-9300, 01-703-527-3887

Icons in SDS

Company Information

company name

TEVA

e-mail address of the competent person responsible for the Safety Data Sheet

TevaSDSRequest@tevapharm.com

Section 2

SECTION 2: Hazards identification

Product definition

This product consists of odorless, white tablets which are round

Health hazards

In the workplace, dusts from damaged tablets may cause irritation of contaminated skin or eye Inhalation of dusts may be harmful. Non-therapeutic ingestion may be harmful. Ingestion of large amount may be fatal due to serious gastrointestinal and/or cardiovascular system effects. In therapeutic use, the most common adverse effects reported are upset stomach and other gastric upset. Therapeutic use of Ketorolac Tromethamine can cause peptic ulcers, gastrointestinal bleeding and/or perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. As a NSAID, therapeutic use of Ketorolac Tromethamine may cause an increased risk of serious cardiovascular thrombotic events, sometimes fatal. This risk may increase with duration of use. Severe anaphylactic reactions can occur in persons allergic to NSAIDs. As a NSAID, may cause harm to the fetus during pregnancy. Limited evidence of mutagenic effect, based on animal information. These effects may be possible as a result of workplace exposure. Refer to Section 11 (Toxicological Information) for additional information on adverse effects. Flammability Hazards: This product is combustible and can ignite if highly heated or if exposed to direct flame. When involved in a fire, this product may decompose and produce irritating vapors and toxic compounds (including carbon, magnesium, titanium, and nitrogen oxides). Reactivity Hazards: This product is not reactive.

Environmental hazards

The active ingredient is toxic to aquatic organism and can cause long-term harm to aquatic organisms if accidentally released. All environmental release should be avoided. Emergency Recommendations: Emergency responders must wear personal protective equipment suitable for the situation to which they are responding.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.